These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7775137)
1. Hepatoma/merbarone. A Southwest Oncology Group study. Poplin EA; Tangen CM; Harvey WH; Macdonald JS Invest New Drugs; 1994; 12(4):337-40. PubMed ID: 7775137 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study. Slavik M; Liu PY; Kraut EH; Natale RB; Flaherty LE; Sondak VK Invest New Drugs; 1995; 13(2):143-7. PubMed ID: 8617577 [TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of merbarone in renal cell carcinoma. Flanigan RC; Saiers JH; Wolf M; Kraut EH; Smith AY; Blumenstein B; Crawford ED Invest New Drugs; 1994; 12(2):147-9. PubMed ID: 7860233 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study. Kraut EH; Fleming T; Macdonald JS; Spiridonidis CH; Bradof JE; Baker LH Am J Clin Oncol; 1993 Aug; 16(4):327-8. PubMed ID: 8328410 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group study. Kraut EH; Bendetti J; Balcerzak SP; Doroshow JH Invest New Drugs; 1992 Nov; 10(4):347-9. PubMed ID: 1487411 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of merbarone in patients with malignant brain tumors. Malik UR; Dutcher JP; Caliendo G; Lasala P; Mitnick R; Wiernik PH Med Oncol; 1997; 14(3-4):159-62. PubMed ID: 9468039 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of merbarone in patients with adenocarcinoma of the pancreas. Jones DV; Ajani JA; Winn RJ; Daugherty KR; Levin B; Krakoff IH Cancer Invest; 1993; 11(6):667-9. PubMed ID: 8221199 [TBL] [Abstract][Full Text] [Related]
9. Phase I clinical and pharmacological study of merbarone. Dimaggio JJ; Warrell RP; Muindi J; Stevens YW; Lee SJ; Lowenthal DA; Haines I; Walsh TD; Baltzer L; Yaldaei S Cancer Res; 1990 Feb; 50(4):1151-5. PubMed ID: 2297763 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma. Ajani JA; Winn R; Baez L; Pollock T; Maher T; Hallinan-Fueger B; Newman J Cancer Invest; 1994; 12(5):488-90. PubMed ID: 7922705 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study. Look KY; Blessing JA; Adelson MD; Morris M; Bookman MA Am J Clin Oncol; 1996 Feb; 19(1):7-9. PubMed ID: 8554040 [TBL] [Abstract][Full Text] [Related]
12. A phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. Look KY; Blessing JA; Williams L; Morris M Am J Clin Oncol; 1995 Oct; 18(5):441-3. PubMed ID: 7572765 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study. Bukowski RM; Legha S; Saiki J; Eyre HJ; O'Bryan R Cancer Treat Rep; 1982 Aug; 66(8):1651-2. PubMed ID: 6286120 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group study. Wall JG; Benedetti JK; O'Rourke MA; Natale RB; Macdonald JS Invest New Drugs; 1997; 15(3):257-60. PubMed ID: 9387049 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study. Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510 [No Abstract] [Full Text] [Related]
16. [Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)]. Rougier P; Ychou M; Droz JP Bull Cancer; 1988; 75(10):979-81. PubMed ID: 2851337 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study. Harvey WH; Fleming TR; Beltran G; Saiers JH; Oishi N; Von Hoff DD Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482 [No Abstract] [Full Text] [Related]
19. Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three cases. Romano O; Truant S; Sergent-Baudson G; Comet B; Pruvot FR; Hebbar M J Chemother; 2008 Aug; 20(4):518-20. PubMed ID: 18676236 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]